• 1. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 4. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 5. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960

3-(1,1-difluoroethyl)bicyclo[1.1.1]pentan-1-amine; hydrochloride (CAS No. 1886967-27-6): An Emerging Compound in Medicinal Chemistry

3-(1,1-difluoroethyl)bicyclo[1.1.1]pentan-1-amine; hydrochloride (CAS No. 1886967-27-6) is a novel compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural features and potential therapeutic applications. This compound belongs to the class of bicyclic amines and is characterized by the presence of a difluoroethyl group, which imparts distinct chemical and biological properties.

The bicyclo[1.1.1]pentane scaffold is a relatively new and promising structural motif in drug discovery. This scaffold has been explored for its ability to enhance the physicochemical properties of molecules, such as solubility, stability, and bioavailability, while maintaining or improving their biological activity. The introduction of the difluoroethyl group further modulates these properties, offering a unique combination of steric and electronic effects that can influence receptor binding and pharmacological profiles.

Recent studies have highlighted the potential of 3-(1,1-difluoroethyl)bicyclo[1.1.1]pentan-1-amine; hydrochloride in various therapeutic areas. One notable application is in the treatment of central nervous system (CNS) disorders, where this compound has shown promising results as a modulator of neurotransmitter systems. Specifically, it has been investigated for its ability to interact with serotonin receptors, which are implicated in conditions such as depression, anxiety, and schizophrenia.

In preclinical studies, 3-(1,1-difluoroethyl)bicyclo[1.1.1]pentan-1-amine; hydrochloride has demonstrated favorable pharmacokinetic properties, including good oral bioavailability and low toxicity profiles. These characteristics make it an attractive candidate for further development as a potential therapeutic agent.

The synthesis of 3-(1,1-difluoroethyl)bicyclo[1.1.1]pentan-1-amine; hydrochloride involves several key steps that highlight the synthetic versatility of the bicyclic scaffold. The initial step typically involves the formation of the bicyclo[1.1.1]pentane core through a ring-closing metathesis reaction or other cyclization methods. Subsequent functionalization steps introduce the difluoroethyl group and the amine functionality, which are crucial for its biological activity.

The unique structure of 3-(1,1-difluoroethyl)bicyclo[1.1.1]pentan-1-amine; hydrochloride also makes it an interesting candidate for structure-activity relationship (SAR) studies. By systematically modifying different parts of the molecule, researchers can gain insights into how specific structural features influence its biological activity and selectivity towards different receptors or enzymes.

In addition to its potential as a therapeutic agent, 3-(1,1-difluoroethyl)bicyclo[1.1.1]pentan-1-amine; hydrochloride has also been explored as a tool compound in academic research settings. Its well-defined structure and known biological activities make it useful for probing receptor mechanisms and understanding the underlying biology of various diseases.

Despite its promising potential, further research is needed to fully elucidate the mechanisms of action and optimize its therapeutic profile. Ongoing clinical trials are evaluating its safety and efficacy in human subjects, with initial results showing positive trends in terms of both safety and preliminary efficacy.

In conclusion, 3-(1,1-difluoroethyl)bicyclo[1.1.1]pentan-1-amine; hydrochloride (CAS No. 1886967-27-6) represents an exciting development in medicinal chemistry with potential applications in treating CNS disorders and other conditions. Its unique structural features and favorable pharmacological properties make it a valuable addition to the growing arsenal of compounds being explored for their therapeutic potential.

• 1049763-69-0(4,4-difluoroadamantan-1-amine hydrochloride)
• 2402828-89-9(8,8-Difluorodispiro[2.0.34.13]octan-6-amine;hydrochloride)
• 2108549-79-5(3-(Difluoromethyl)bicyclo[1.1.1]pentan-1-amine hydrochloride)
• 1380300-69-5(1-(Cyclobutylmethyl)-4,4-difluorocyclohexan-1-amine hydrochloride)
• 1955540-34-7(2,2-difluorospiro[2.3]hexan-5-amine;hydrochloride)
• 1408076-03-8(3,3-difluoro-1-methylcyclobutan-1-amine)
• 1886967-26-5(3-(1,1-Difluoroethyl)bicyclo[1.1.1]pentan-1-amine)
• 1523606-39-4(3,3-difluoro-1-methylcyclobutan-1-amine hydrochloride)
• 1865764-59-5((2S,4R)-5,5-Difluorospiro[3.3]heptan-2-amine hydrochloride)
• 1423032-71-6(6,6-Difluorospiro[3.3]heptan-2-amine hydrochloride)